Pharmaceutical services strengthen the brazilian Unified Health System: experience of the practice of technical and clinical activities that result in safety




Unified Health System; Pharmaceutical Services; Evidence-Based Pharmacy Practice; Patient-Centered Care; Patient safety.


Objective: To report the experience of the practice of pharmaceutical services in a hospital of the Unified Health System (Sistema Único de Saúde - SUS) and describe the development outcomes of the technical and clinical activities performed. Method: A descriptive study, with an experience report, was carried out at the Hospital Estadual de Ribeirão Preto, in the year 2021. The institution is a medium-sized hospital complex that provides health care (hospital and outpatient) to Ribeirão Preto, State of São Paulo, and 25 other neighboring municipalities. Pharmaceutical services were performed by nine pharmacists and a pharmacy assistant, as well as being characterized by operational and clinical practices. The report of the sector's daily life was then detailed as a successful experience of the SUS. Results: Pharmaceutical services were structured through an institutional policy of safety in the use of medicines, which standardized the selection and distribution of medicines, taking into account good practices and the adoption of methods to avoid errors and adverse events. In addition, clinical services related to pharmaceutical care included medication reconciliation, pharmacotherapy review and pharmacotherapeutic follow-up, which were guided by evidence-based health practice. A 91.3% rate of acceptance by the health team to the actions of pharmaceutical services provided validation of the method used and the more than 750 interventions (technical and clinical) carried out supported the success of the experience. Conclusion: This study exposed a real-life experience related to the development of pharmaceutical services in a SUS hospital institution and it can support the structuring of these practices in other similar units.


American Geriatrics Society. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 67(4), 674-694. doi: 10.1111/jgs.15767

Ayalew, M. B., Tegegn, H. G. & Abdela, O. A. (2019). Drug related hospital admissions; a systematic review of the recent literatures. Bulletin of Emergency and Trauma, 7(4), 339-46. doi: 10.29252/beat-070401

Bernardes, J. M., Ruiz-Frutos, C., Moro, A. R. P. & Dias, A. (2021). A low-cost and efficient participatory ergonomic intervention to reduce the burden of work-related musculoskeletal disorders in an industrially developing country: an experience report. International Journal of Occupational Safety and Ergonomics, 27(2), 452-9. doi: 10.1080/10803548.2019.1577045

Couto, R. C., Pedrosa, T. M. G. & Rosa, M. B. (2016). Erros acontecem: A força da transparência no enfrentamento dos eventos adversos assistenciais em pacientes hospitalizados. Belo Horizonte, Brasil: UFMG/IESS.

da Silva, K. F., Torres, A. S. F. & Soler, O. (2022). Evidências sobre tipos de intervenções para a institucionalização da assistência farmacêutica: revisão integrativa. Research, Society and Development, 11(3), e55811326979. doi: 10.33448/rsd-v11i3.26979

de Oliveira, A. M., Varallo, F. R., Rodrigues, J. P. V., Aguilar, G. J., Lima, N. K. C. & Pereira, L. R. L. (2022). Contribution of Pharmaceutical Care to Person-centered Health Care and the Safety of Pharmacotherapy for Hospitalized Older Individuals in Brazil: An Investigative Single-arm Intervention Trial. Current Drug Safety, 17. doi: 10.2174/157488631766622061414043

Fu, A. Z., Jiang, J. Z., Reeves, J. H., Fincham, J. E., Liu, G. G. & Perri III, M. (2007). Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Medical Care, 45(5), 472-6. doi: 10.1097/01.mlr.0000254571.05722.34

Graabæk, T. & Kjeldsen, L. J. (2013). Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic Review. Basic & Clinical Pharmacology & Toxicology, 112(6), 359-73. doi: 10.1111/bcpt.12062

Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M. & Bates, D. W. (2003). Incidence and preventability of adverse drug events among older persons in the ambulatory setting. Jama, 289(9), 1107-16. doi: 10.1001/jama.289.9.1107

Gurwitz, J. H., Field, T. S., Judge, J., Rochon, P., Harrold, L. R., Cadoret, C., Lee, M., White, K., LaPrino, J., Erramuspe-Mainard, J., DeFlorio, M., Gavendo, L., Auger, J. & Bates, D. W. (2005). The incidence of adverse drug events in two large academic long-term care facilities. The American Journal of Medicine, 118(3), 251-8. doi: 10.1016/j.amjmed.2004.09.018

Institute for Safe Medication Practices. (2018). High-Alert Medication Survey Results Lead to Several Changes for 2018. Pennsylvania, USA: Institute for Safe Medication Practices. Retrieved from

Law, M. G., Maposa, P., Steeb, D. R. & Duncan, G. (2017). Addressing the global need for public health clinical pharmacists through student pharmacist education: a focus on developing nations. International Journal of Clinical Pharmacy, 39(6), 1141–4. doi: 10.1007/s11096-017-0537-0

Lee, V. W., Yi, P. T., Kong, K. W., Chan, P. K. & Kwok, F. L. (2013). Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong. Geriatrics & Gerontology International, 13(1), 175–81. doi: 10.1111/j.1447-0594.2012.00881.x

León, M. P., Ramos, H. A., Munguía, S. G., Penichet, S. M. M. & Gómez, R. M. (2014). Evaluación de la calidad de las intervenciones farmacéuticas en urgencias basada en la evidencia científica. Farmacia Hospitalaria, 38(2), 123-9. doi: 10.7399/FH.2014.38.2.981

Magid, D. J., Olson, K. L., Billups, S. J., Wagner, N. M., Lyons, E. E. & Kroner, B. A. (2013). A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circulation Cardiovascular Quality and Outcomes, 6(2), 157–63. doi: 10.1161/CIRCOUTCOMES.112.968172

Makary, M. A. & Daniel, M. (2016). Medical error—the third leading cause of death in the US. British Medical Journal, 353. doi: 10.1136/bmj.i2139

Marques, L. A. M. (2013). Geriatria. Atenção farmacêutica em distúrbios maiores. 2 ed. São Paulo, Brasil: Medfarma.

Ministério da Saúde. (2015). Cuidado Farmacêutico na Atenção Básica. Brasília, Brasil: Ministério da Saúde.

Ministério da Saúde. (2020). RDC Nº 406 - Dispõe sobre as Boas Práticas de Farmacovigilância para Detentores de Registro de Medicamento de uso humano, e dá outras providências. Brasília, Brasil: Ministério da Saúde.

Morais, D. A., Moraes, C. M. G., Souza, K. M. & Alves, R. L. (2021). Mobile pre-hospital care reorganization during the COVID-19 pandemic: experience report. Revista Brasileira de Enfermagem, 75(Suppl 1), e20200826. doi: 10.1590/0034-7167-2020-0826

Pande, S., Hiller, J. E., Nkansah, N. & Bero, L. (2013). The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database of Systematic Reviews, (2). doi: 10.1002/14651858.CD010398

Rodrigues, J. P. V., Marques, F. A., Gonçalves, A. M. R. F., Campos, M. S. A., dos Reis, T. M., Morelo, M. R. S., Fontoura, A., Girolineto, B. M. P., Souza, H. P. M. C., Cazarim, M. S., Maduro, L. C. S. & Pereira, L. R. L. (2019). Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PloS one, 14(1), e0210779. doi: 10.1371/journal.pone.0210779

Suggett, E. & Marriott, J. (2016). Risk Factors Associated with the Requirement for Pharmaceutical Intervention in the Hospital Setting: A Systematic Review of the Literature. Drugs - Real World Outcomes, 3(3), 241-63. doi: 10.1007/s40801-016-0083-4

World Health Organization. (1997). The role of the pharmacist in the health care system: preparing the future pharmacist. Geneva, Switzerland: World Health Organization.

World Health Organization. (2004). World alliance for patient safety: forward programme. Geneva, Switzerland: World Health Organization.

World Health Organization. (2006). Developing pharmacy practice: a focus on patient care. Geneva, Switzerland: World Health Organization.

World Health Organization. (2007). Report on the results of the web-based modified delphi survey of the international classification for patient safety overview. Geneva, Switzerland: World Health Organization.

World Health Organization. (2017). Medication without harm: global patient safety challenge on medication safety. Geneva, Switzerland: World Health Organization.



How to Cite

OLIVEIRA, A. M. de .; FILIPIN, M. D. V.; REIS, D. A.; MONTEIRO, L. M. M.; CUBAYACHI, C.; MADRUGA, I. R. R.; GIARDINI, M. H. Pharmaceutical services strengthen the brazilian Unified Health System: experience of the practice of technical and clinical activities that result in safety. Research, Society and Development, [S. l.], v. 11, n. 14, p. e15111435645, 2022. DOI: 10.33448/rsd-v11i14.35645. Disponível em: Acesso em: 5 jun. 2023.



Health Sciences